Yatharth Hospital Intrinsic Value
Yatharth Hospital (YATHARTH) median intrinsic value is ₹243.97 from 9 valuation models (range ₹186–₹407), vs current price ₹813.25 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Browse Yatharth Hospital financial data for revenue, profit, balance sheet and cash flow data.
YATHARTH Valuation Methods Summary — DCF, Graham Number & P/E
Yatharth Hospital intrinsic value across 9 models vs current price ₹813.25 — upside/downside and value range per method. Also explore Yatharth Hospital stock price data download to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹243.97 | ₹195.18 - ₹292.76 | -70.0% | EPS: ₹19.72, Sector P/E: 12x |
| Book Value Method | asset | ₹185.52 | ₹166.97 - ₹204.07 | -77.2% | Book Value/Share: ₹185.52, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹243.97 | ₹219.57 - ₹268.37 | -70.0% | Revenue/Share: ₹145.42, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹325.30 | ₹292.77 - ₹357.83 | -60.0% | EBITDA: ₹348.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹325.30 | ₹260.24 - ₹390.36 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹243.97 | ₹219.57 - ₹268.37 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹243.97 | ₹219.57 - ₹268.37 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹406.62 | ₹365.96 - ₹447.28 | -50.0% | ROE: 10.1%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹286.91 | ₹258.22 - ₹315.60 | -64.7% | EPS: ₹19.72, BVPS: ₹185.52 |
YATHARTH Intrinsic Value vs Market Price — All Valuation Models
Yatharth Hospital fair value range ₹186–₹407 vs current market price ₹813.25 across 9 valuation models. For current market price and key ratios, visit Yatharth Hospital stock price NSE.
YATHARTH Intrinsic Value Analysis — Undervalued or Overvalued?
Yatharth Hospital median intrinsic value ₹243.97, current price ₹813.25 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of YATHARTH?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Yatharth Hospital (YATHARTH) is ₹243.97 (median value). With the current market price of ₹813.25, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹185.52 to ₹406.62, indicating ₹185.52 - ₹406.62.
Is YATHARTH undervalued or overvalued?
Based on our multi-method analysis, Yatharth Hospital (YATHARTH) appears to be trading above calculated value by approximately 70.0%.
YATHARTH Financial Health — Key Ratios vs Industry Benchmarks
Yatharth Hospital financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.45 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 10.1% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 23.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.61x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
YATHARTH Cash Flow Quality — Operating & Free Cash Flow
Yatharth Hospital operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹150 Cr | ₹-60 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹-3 Cr | ₹-116 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹64 Cr | ₹54 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹60 Cr | ₹34 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹44 Cr | ₹34 Cr | Positive Free Cash Flow | 8/10 |